CONFIDENTIAL — FINALAdaptimmune Therapeutics PLC • November 2nd, 2017 • Biological products, (no disgnostic substances)
Company FiledNovember 2nd, 2017 IndustryCONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.